Legal Questions Swirl Around FDA's New Expedited Drug Program

(MedPage Today) — Efforts by FDA Commissioner Marty Makary, MD, MPH, to dramatically shorten review of drugs favored by President Donald Trump’s administration are raising concern within the agency, stoking fears that the plan could run counter…